Dr. Frances Cheng – Specialist in Psychiatry

Languages: English, Mandarin, Cantonese


Dr. Cheng has extensive experience of working in both the public and private sectors.  She received her psychiatric training in Hong Kong and in the UK where she was a Specialist Registrar of the Cambridgeshire and Peterborough Foundation Trust.  She has also worked at Global HealthCare, a private, multi-specialty clinic in Shanghai which mainly caters for the expatriate population.  During her time at Global HealthCare, Dr. Cheng treated a range of mental illness including adjustment, anxiety and mood disorders, anger management, post-traumatic stress disorder for victims of school and workplace bullying and sexual assault, eating disorders, body image disorders, drug and alcohol misuse, bipolar affective disorders and schizophrenia.   Prior to joining the Alpha Clinic, Dr. Cheng held the position of Clinical Assistant Professor at the Department of Psychiatry of the University of Hong Kong at Queen Mary Hospital.

Dr. Cheng obtained her medical degree from the University of Hong Kong in 2001 and a Masters in Epidemiology from the London School of Hygiene and Tropical Medicine. She is a Member of the Royal College of Psychiatrists of the United Kingdom and a Fellow of the Hong Kong College of Psychiatrists.


  • Bachelor of Medicine and Bachelor of Surgery, University of Hong Kong
  • Masters in Epidemiology, London School of Hygiene and Tropical Medicine
  • Member of the Royal College of Psychiatrists, United Kingdom
  • Fellow of the Hong Kong College of Psychiatrists


  • Residency in Hong Kong
  • Specialist Registrar in Cambridge
  • Academic Clinical Fellow at the Department of Psychiatry, University of Cambridge
  • Clinical Assistant Professor at the Department of Psychiatry, University of Hong Kong
  • Specialist in Psychiatry at Global HealthCare Shanghai
  • Special interest in eating disorders, mood disorders and schizophrenia

Selected Publications

1. Cheng F and Jones PB, Drug treatments for schizophrenia: pragmatism in trial design shows lack of progress in drug design. Epidemiology and Psychiatric Sciences, 2013. 22(3): p. 223-233. dx.doi.org

2. Scoriels L, Barnett JH, Murray GK, Cherukuru S, Fielding M, Cheng F, Lennox BR, Sahakian BJ, and Jones PB, Effects of Modafinil on Emotional Processing in First Episode Psychosis. Biological Psychiatry, 2011. 69(5): p. 457-464. dx.doi.org

3. Cheng F, Kirkbride JB, Lennox BR, Perez J, Masson K, Lawrence K, Hill K, Feeley L, Painter M, Murray GK, Gallagher O, Bullmore ET, and Jones PB, Administrative incidence of psychosis assessed in an early intervention service in England: first epidemiological evidence from a diverse, rural and urban setting. Psychological Medicine, 2011. 41(5): p. 949-958. dx.doi.org

4. Murray GK, Cheng F, Clark L, Barnett JH, Blackwell AD, Fletcher PC, Robbins TW, Bullmore ET, and Jones PB, Reinforcement and reversal learning in first-episode psychosis. Schizophrenia Bulletin, 2008. 34(5): p. 848-855. dx.doi.org


Books & Book Chapters

1. F Cheng, PB Jones and PS Talbot. Chapter "Antipsychotics" in book 'Fundamentals of Clinical Psychopharmacology' Fourth Edition ed. Ian M Anderson and Ian C Reid 2015. CRC Press, Taylor and Francis Group.

2. Frances Cheng and Peter B. Jones. Chapter "Atypical vs. conventional treatment in schizophrenia in practice: another triumph of hope over experience?" in book ‘Therapeutic Strategies in Schizophrenia’ ed. Peter McKenna and Ann Mortimer 2010, Clinical Publishing, Atlas Medical Publishing Ltd.